Botanix Pharmaceuticals
Botanix Pharmaceuticals

Botanix Pharmaceuticals Information

Contact top employees from Botanix Pharmaceuticals

Summary

Botanix Pharmaceuticals is a public company that has been in the industry for 23 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals areas. The position of the President is occupied by Vince Ippolito. Its headquarters is located at Northbridge, Western Australia, AU. The number of employees ranges from 1 to 25. The annual revenue of Botanix Pharmaceuticals varies between 100K and 5.0M. Total funding of the company - $53M. To connect with Botanix Pharmaceuticals employee register on SignalHire.

Industries

Pharmaceuticals

Headquarters Location

Employees Size

10-50 employees

Specialties

Medical dermatology, hyperhidrosis, rosacea, dermatitis, acne, antimicrobial

SIC Code

2834

Founded

2002

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Independent Company

Contact Botanix Pharmaceuticals

Organization Website

Social Links

facebookfacebooklinkedIntwitter

Phone Number

+61 8 6285 0083

Competitors

Founded
Type
Employees
Revenue
Funding
2016Public
Company
25 - 100 < 1M $97.5M
2009Privately
Held
100 - 250 5M $148.1M
1997Public
Company
25 - 100 8.8M $75M
1994Public
Company
500 - 1.0K 313.8M $127.8M
2011Privately
Held
5000-10000 < 1M $31.8M
2014- 7 < 1M $41.2M
2001Public
Company
25 - 100 19M $0
1981Privately
Held
1.0K - 5.0K 3.1B $0
1950Public
Company
1.0K - 5.0K 549M $0
2002- 1000-5000 - $-
2002- 5000-10000 - $-
2010- 100-200 - $-
2003- 100-200 - $-
1944- 1000-5000 - $-
2014- 500-1000 - $-
-- 10-50 - $-

Employees Turnover 3 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Botanix Pharmaceuticals shows a diverse range of experience levels:
9% have been with the company for less than 1 year18% for 1–2 years18% for 3–4 years27% for 5–7 years18% for 8–10 years9% have over 11 years of service at Botanix Pharmaceuticals
Ex-employees positions
In Company
In New Company
Contact top employees from Botanix Pharmaceuticals
Piyush Jain
Vice President of Technical Services
View
Kirk Meyer
Territory Manager
View
Meng Jia
Senior Director - Data Engineering
View
Reid Shea
Regional Sales Manager - South Central
View
Kate Allen
Territory Manager
View
Ana Gioffre
Territory Manager
View
Aaron Correa
Territory Manager- Dermatology
View
Dana Mackie
Territory Manager
View
Sherry Emly
Dermatology Sales Representative at Botanix Pharmaceuticals
View
Emily Trenchard
Territory Manager
View
Jeanne Kim
Territory Manager
View
Chris Balija
Regional Manager - West
View
Kaitlyn Sadallah
Territory Manager
View
Leisha Martin
Vice President, Quality, Regulatory and Pharmacovigilance
View
Johanna Carcache
Territory Manager
View
Howie McKibbon
Chief Executive Officer
View
Nikki Tran
Territory Manager
View
Vince Ippolito
President and Executive Chairmen
View
Christopher Rudicil
Territory Manager
View
Martina Cartwright
Vice President, Medical Affairs
View
Bob Abeyta
Senior Director of Supply Chain
View
Kim Magalong Binsfeld
Director Med Info, PV, ClinOps
View
Aaron Sookhoo
Professional Speaker
View
Boris Meyerson
Chief Business Officer
View
Kevin Wojciechowski
Head of HCP Marketing & Sales Training
View
Romy Gross
Territory Manager
View
Melanie Davis Foster
Territory Manager
View
Carey Herbert
Chief Legal & Compliance Officer
View
Darin Van Arsdalen
Director of Sales Operations
View

FAQ

Botanix Pharmaceuticals operates in the Pharmaceuticals industries. More details can be found on the official website: botanixpharma.com.
The headquarters of Botanix Pharmaceuticals are located in North Perth, Australia.
The current CEO of Botanix Pharmaceuticals is Vince Ippolito
You can contact Botanix Pharmaceuticals by phone at +61 8 6285 0083.
Botanix Pharmaceuticals currently employs 10-50 people.
Botanix Pharmaceuticals's revenue is approximately 1.9M.
Well-known competitors of Botanix Pharmaceuticals include Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), Suneva Medical, Sol-Gel and Mayne Pharma.
BACK TO TOP